Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|October 6, 2006
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletionAlan List, Gordon Dewald, John Bennett, et al.
British Journal of Haematology|February 9, 2010
Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-CPierre Fenaux, Norbert Gattermann, John F Seymour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
A phase I study of oral ARRY-614, a p38 MAPK/Tie2 dual inhibitor, in patients with low or intermediate-1 risk myelodysplastic syndromesGuillermo Garcia-Manero, Hanna J Khoury, Elias Jabbour, et al.
Leukemia & Lymphoma|October 25, 2008
Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironmentTony Navas, Li Zhou, Myka Estes, et al.
Blood|August 11, 2011
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3AAnna M Jankowska, Hideki Makishima, Ramon V Tiu, et al.
Cancer Medicine|April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomideDana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Leukemia|July 21, 2018
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMMLSandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, et al.
The Lancet. Oncology|February 24, 2009
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyPierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeMohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
The Journal of Clinical Investigation|November 13, 2013
Induction of myelodysplasia by myeloid-derived suppressor cellsXianghong Chen, Erika A Eksioglu, Junmin Zhou, et al.
Pageof 7